Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine-Reference-Cited by-同舟云学术

Monovalent Omicron COVID-19 vaccine triggers superior neutralizing antibody responses against Omicron subvariants than Delta and Omicron bivalent vaccine

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Li Wanting¹,Zhao Tiantian²,Tao Bai³,Zhao Liwei⁴,Xiao Hang⁵,Ding Xinyu⁶,Li Chuang⁴,Chen Lin⁷,Cheng Hao⁵,Lou Yang⁵,Chen Yuxin⁴⁸,Wu Chao¹⁸

Affiliation:

1. Department of Infectious Diseases, Nanjing Drum Tower Hospital Clinical College of Xuzhou Medical University, Nanjing, Jiangsu, China

2. Department of Infectious Disease, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China

3. Department of Infectious Diseases, Wuhan Jinyintan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Clinical Research Center for Infectious Diseases, Wuhan, Hubei, China

4. Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China

5. Yurogen Biosystem LLC, Wuhan, Hubei, China

6. Department of Biological Engineering, Nanjing University of Science and Technology, Nanjing, Jiangsu, China

7. Department of Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, Jiangsu, China

8. Institute of Viruses and Infectious Diseases, Nanjing University, Nanjing, Jiangsu, China

Funder

the Training Program of the Major Research Plan of the National Natural Science Foundation of China

the Scientific Research Project of Jiangsu Health Commission

the Major Research Plan of the National Natural Science Foundation of China

Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2264589

Reference44 articles.

1. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

2. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

3. SARS-CoV-2 hybrid immunity: silver bullet or silver lining?

4. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines

5. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection